The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.
The fat side of prostate cancer
Open accessAbstract
Prostate cancer (PCa) metabolism appears to be unique in comparison with other type of solid cancers. Normal prostate cells mainly rely on glucose oxidation to provide precursors for the synthesis and secretion of citrate, resulting in an incomplete Krebs cycle and minimal oxidative phosphorylation for energy production. In contrast, during transformation, PCa cells no longer secrete citrate and they reactivate the Krebs cycle as energy source. Moreover, primary PCas do not show increased aerobic glycolysis and therefore they are not efficiently detectable with 18F-FDG-PET. However, increased de novo lipid synthesis, strictly intertwined with deregulation in classical oncogenes and oncosuppressors, is an early event of the disease. Up-regulation and increased activity of lipogenic enzymes (including fatty acid synthase and choline kinase) occurs throughout PCa carcinogenesis and correlates with worse prognosis and poor survival. Thus, lipid precursors such as acetate and choline have been successfully used as alternative tracers for PET imaging. Lipid synthesis intermediates and FA catabolism also emerged as important players in PCa maintenance. Finally, epidemiologic studies suggested that systemic metabolic disorders including obesity, metabolic syndrome, and diabetes as well as hypercaloric and fat-rich diets might increase the risk of PCa. However, how metabolic disorders contribute to PCa development and whether dietary lipids and de novo lipids synthesized intra-tumor are differentially metabolized still remains unclear. In this review, we examine the switch in lipid metabolism supporting the development and progression of PCa and we discuss how we can exploit its lipogenic nature for therapeutic and diagnostic purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,070
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
Petrylak, D. P., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Jones, J. A., Taplin, M. E., Burch, P. A., Berry, D., Moinpour, C., Kohli, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041318 · Cited by 3,665
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Activation of a metabolic gene regulatory network downstream of mTOR complex 1
Düvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.022 · Cited by 2,020
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,778
Steinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
SREBP transcription factors: master regulators of lipid homeostasis
Eberlé, D., Hegarty, B., Bossard, P., Ferré, P., & Foufelle, F. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.018 · Cited by 1,529
International Variation in Prostate Cancer Incidence and Mortality Rates
Center, M. M., Jemal, A., Lortet-Tieulent, J., Ward, E., Ferlay, J., Brawley, O., & Bray, F. (2012) · European Urology · doi:10.1016/j.eururo.2012.02.054 · Cited by 1,521
Montgomery, R. B., Mostaghel, E. A., Vessella, R., Hess, D. L., Kalhorn, T. F., Higano, C. S., True, L. D., & Nelson, P. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0249 · Cited by 1,419
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Porstmann, T., Santos, C. R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J. R., Chung, Y.-L., & Schulze, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.007 · Cited by 1,413
Targeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411
Biochemistry of Lipids, Lipoproteins and Membranes
(2021) · Elsevier eBooks · doi:10.1016/c2020-0-00089-7 · Cited by 1,400
G-protein-coupled receptors and cancer
Dorsam, R. T., & Gutkind, J. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2069 · Cited by 1,388
Santos, C. R., & Schulze, A. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08644.x · Cited by 1,335
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J. (2012) · Nature · doi:10.1038/nature10642 · Cited by 1,328
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
Palmitoylation: policing protein stability and traffic
Linder, M. E., & Deschenes, R. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2084 · Cited by 1,185
Wang, S., Gao, J., Lei, Q., Rozengurt, N., Pritchard, C., Jiao, J., Thomas, G. V., Li, G., Roy-Burman, P., Nelson, P. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00215-0 · Cited by 1,109
ATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086
Lipid Droplets Finally Get a Little R-E-S-P-E-C-T
Farese, R. V., & Walther, T. C. (2009) · Cell · doi:10.1016/j.cell.2009.11.005 · Cited by 1,022
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis
Nomura, D. K., Long, J. Z., Niessen, S., Hoover, H. S., Ng, S.-W., & Cravatt, B. F. (2010) · Cell · doi:10.1016/j.cell.2009.11.027 · Cited by 1,002
Cancer Cell Metabolism: One Hallmark, Many Faces
Cantor, J. R., & Sabatini, D. M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0345 · Cited by 947
Conversion of α -linolenic acid to longer-chain polyunsaturated fatty acids in human adults
Burdge, G. C., & Calder, P. C. (2005) · Reproduction Nutrition Development · doi:10.1051/rnd:2005047 · Cited by 939
A Retroviral Oncogene, akt , Encoding a Serine-Threonine Kinase Containing an SH2-Like Region
Bellacosa, A., Testa, J. R., Staal, S. P., & Tsichlis, P. N. (1991) · Science · doi:10.1126/science.1833819 · Cited by 939
Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.005 · Cited by 925
Molecular mechanisms of cancer development in obesity
Khandekar, M. J., Cohen, P., & Spiegelman, B. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3174 · Cited by 907
Lipotoxicity: when tissues overeat
Schaffer, J. E. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200306000-00008 · Cited by 896
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
Freed-Pastor, W. A., Mizuno, H., Zhao, X., Langerød, A., Moon, S.-H., Rodriguez-Barrueco, R., Barsotti, A., Chicas, A., Li, W., Polotskaia, A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.017 · Cited by 865
Sahra, I. B., Laurent, K., Loubat, A., Giorgetti-Peraldi, S., Colosetti, P., Auberger, P., Tanti, J. F., Le Marchand-Brustel, Y., & Bost, F. (2008) · Oncogene · doi:10.1038/sj.onc.1211024 · Cited by 861
Adipokines and Insulin Resistance
Rabe, K., Lehrke, M., Parhofer, K. G., & Broedl, U. C. (2008) · Molecular Medicine · doi:10.2119/2008-00058.rabe · Cited by 808
Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology
Kuhajda, F. P. (2000) · Nutrition · doi:10.1016/s0899-9007(99)00266-x · Cited by 788
Monounsaturated Fatty Acid Modification of Wnt Protein: Its Role in Wnt Secretion
Takada, R., Satomi, Y., Kurata, T., Ueno, N., Norioka, S., Kondoh, H., Takao, T., & Takada, S. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.003 · Cited by 788
Staal, S. P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5034 · Cited by 767
Locke, J. A., Guns, E. S., Lubik, A. A., Adomat, H. H., Hendy, S. C., Wood, C. A., Ettinger, S. L., Gleave, M. E., & Nelson, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5997 · Cited by 747
Li, S., Brown, M. S., & Goldstein, J. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914798107 · Cited by 733
A microenvironmental model of carcinogenesis
Gatenby, R. A., & Gillies, R. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2255 · Cited by 721
Rysman, E., Brusselmans, K., Scheys, K., Timmermans, L., Derua, R., Munck, S., Van Veldhoven, P. P., Waltregny, D., Daniëls, V. W., Machiels, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3871 · Cited by 721
Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
Fatty acid synthesis: a potential selective target for antineoplastic therapy
Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., & Pasternack, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6379 · Cited by 705
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2626 · Cited by 671
Whittemore, A. S., Kolonel, L. N., Wu, A. H., John, E. M., Gallagher, R. P., Howe, G. R., Burch, J. D., Hankin, J., Dreon, D. M., West, D. W., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.9.652 · Cited by 665
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
Shaw, R. J. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01972.x · Cited by 644
Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1
Ben Sahra, I., Regazzetti, C., Robert, G., Laurent, K., Le Marchand-Brustel, Y., Auberger, P., Tanti, J.-F., Giorgetti-Peraldi, S., & Bost, F. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1769 · Cited by 616
Increased lipogenesis in cancer cells: new players, novel targets
Swinnen, J. V., Brusselmans, K., & Verhoeven, G. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232894.28674.30 · Cited by 610
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Kridel, S. J., Axelrod, F., Rozenkrantz, N., & Smith, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3645 · Cited by 607
Structural basis for AMP binding to mammalian AMP-activated protein kinase
Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T., et al. (2007) · Nature · doi:10.1038/nature06161 · Cited by 591
Elongation of long-chain fatty acids
Leonard, A. E., Pereira, S. L., Sprecher, H., & Huang, Y.-S. (2004) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00040-7 · Cited by 584
Zhuang, L., Kim, J., Adam, R. M., Solomon, K. R., & Freeman, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200519935 · Cited by 567
Enoch, H. G., Catalá, A., & Strittmatter, P. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33223-4 · Cited by 558
De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy
Mashima, T., Seimiya, H., & Tsuruo, T. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605007 · Cited by 555
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
Flavin, R., Peluso, S., Nguyen, P. L., & Loda, M. (2010) · Future Oncology · doi:10.2217/fon.10.11 · Cited by 545
Self-citationMostaghel, E. A., Page, S. T., Lin, D. W., Fazli, L., Coleman, I. M., True, L. D., Knudsen, B., Hess, D. L., Nelson, C. C., Matsumoto, A. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3332 · Cited by 529
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
Walsh, P. C. (2002) · PubMed · Cited by 477
Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A., & Wu, M. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.022 · Cited by 469
Costello, L. C., & FRANKLIN, R. B. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-17 · Cited by 457
Porstmann, T., Griffiths, B., Chung, Y.-L., Delpuech, O., Griffiths, J. R., Downward, J., & Schulze, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208802 · Cited by 455
Very long-chain fatty acids: elongation, physiology and related disorders
Kihara, A. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvs105 · Cited by 441
Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase
Göransson, O., McBride, A., Hawley, S. A., Ross, F. A., Shpiro, N., Foretz, M., Viollet, B., Hardie, D. G., & Sakamoto, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706536200 · Cited by 435
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
AMPK, the metabolic syndrome and cancer
Luo, Z., Saha, A. K., Xiang, X., & Ruderman, N. B. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.011 · Cited by 426
Palmitoylation of Ligands, Receptors, and Intracellular Signaling Molecules
Resh, M. D. (2006) · Science's STKE · doi:10.1126/stke.3592006re14 · Cited by 414
Biochemistry of Lipids, Lipoproteins and Membranes
Spector, A. A. (1992) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(92)90069-2 · Cited by 408
AMP-Activated Protein Kinase as a Drug Target
Hardie, D. G. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105304 · Cited by 407
Medes, G., Thomas, A. J., & Weinhouse, S. (1953) · PubMed · Cited by 405
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer
Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1235 · Cited by 403
COMPARTMENTALIZED RAS/MAPK SIGNALING
Mor, A., & Philips, M. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090723 · Cited by 398
Her-2-neu Expression and Progression Toward Androgen Independence in Human Prostate Cancer
Signoretti, S. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1918 · Cited by 397
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Huang, X., Wullschleger, S., Shpiro, N., McGuire, V. A., Sakamoto, K., Woods, Y. L., Mcburnie, W., Fleming, S., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20080557 · Cited by 396
Cancer and Mediterranean dietary traditions.
Trichopoulou, A., Lagiou, P., Kuper, H., & Trichopoulos, D. (2000) · PubMed · Cited by 390
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Migita, T., Ruiz, S., Fornari, A., Fiorentino, M., Priolo, C., Zadra, G., Inazuka, F., Grisanzio, C., Palescandolo, E., Shin, E., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp030 · Cited by 387
Self-citationThe identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes
Berwick, D. C., Hers, I., Heesom, K. J., Moule, S. K., & Tavareá, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204681200 · Cited by 383
Swinnen, J. V., Roskams, T., Joniau, S., Van Poppel, H., Oyen, R., Baert, L., Heyns, W., & Verhoeven, G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10127 · Cited by 381
Buzzai, M., Bauer, D. E., Jones, R. G., DeBerardinis, R. J., Hatzivassiliou, G., Elstrom, R. L., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208622 · Cited by 357
pH control mechanisms of tumor survival and growth
Parks, S. K., Chiche, J., & Pouyssegur, J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22400 · Cited by 357
Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
Fogarty, S., & Hardie, D. G. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.012 · Cited by 350
Sanders, M. J., Ali, Z. S., Hegarty, B. D., Heath, R., Snowden, M. A., & Carling, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706543200 · Cited by 347
Ramı́rez de Molina, A., Rodrı́guez-González, A., Gutiérrez, R., Martı́nez-Piñeiro, L., Sánchez, J. J., Bonilla, F., Rosell, R., & Lacal, J. C. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00920-8 · Cited by 340
Plathow, C., & Weber, W. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045930 · Cited by 328
Chen, Y., Clegg, N. J., & Scher, H. I. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70229-3 · Cited by 324
Igal, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq131 · Cited by 321
Beckers, A., Organe, S., Timmermans, L., Scheys, K., Peeters, A., Brusselmans, K., Verhoeven, G., & Swinnen, J. V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0389 · Cited by 314
Cholesterol and prostate cancer
Pelton, K., Freeman, M. R., & Solomon, K. R. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.006 · Cited by 303
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
Rossi, S., Graner, E., Febbo, P. G., Weinstein, L. J., Bhattacharya, N., Ónody, T., Bubley, G. J., Balk, S. P., & Loda, M. F. (2003) · PubMed · Cited by 301
Self-citationKoh, C. M., Bieberich, C. J., Dang, C. V., Nelson, W. G., Yegnasubramanian, S., & De Marzo, A. M. (2010) · Genes & Cancer · doi:10.1177/1947601910379132 · Cited by 296
Zakikhani, M., Dowling, R. J. O., Sonenberg, N., & Pollak, M. N. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0081 · Cited by 294
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Büll, U., & Jakse, G. (1996) · PubMed · Cited by 289
Ettinger, S. L., Sobel, R., Whitmore, T. G., Akbari, M., Bradley, D. R., Gleave, M. E., & Nelson, C. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2148-2 · Cited by 287
Lipid rafts: signaling and sorting platforms of cells and their roles in cancer
Staubach, S., & Hanisch, F.-G. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.2 · Cited by 284
Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids
Berquin, I. M., Min, Y., Wu, R., Wu, J., Perry, D., Cline, J. M., Thomas, M. J., Thornburg, T., Kulik, G., Smith, A., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31494 · Cited by 282
Brusselmans, K., De Schrijver, E., Verhoeven, G., & Swinnen, J. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0571 · Cited by 277
Wright, J. L., & Stanford, J. L. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9407-y · Cited by 276
Fritz, V., Benfodda, Z., Rodier, G., Henriquet, C., Iborra, F., Avancès, C., Allory, Y., de la Taille, A., Culine, S., Blancou, H., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1064 · Cited by 270
Schrijver, E. D., Brusselmans, K., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2003) · PubMed · Cited by 269
Costello, L. C., Liu, Y., Franklin, R. B., & Kennedy, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28875 · Cited by 267
Cholesterol and prostate cancer
Freeman, M. R., & Solomon, K. R. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10724 · Cited by 266
Swinnen, J. V., Van Veldhoven, P. P., Timmermans, L., De Schrijver, E., Brusselmans, K., Vanderhoydonc, F., Van de Sande, T., Heemers, H., Heyns, W., & Verhoeven, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00265-1 · Cited by 259
The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling
Blasi, F., & Sidenius, N. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.12.039 · Cited by 258
Ramírez de Molina, A., Gutiérrez, R., Ramos, M. A., Silva, J. M., Silva, J., Bonilla, F., Sánchez, J. J., & Lacal, J. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205556 · Cited by 257
Xiang, X., Saha, A. K., Wen, R., Ruderman, N. B., & Luo, Z. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.133 · Cited by 251
Nadolski, M. J., & Linder, M. E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.06056.x · Cited by 251
Costello, L. C., & Franklin, R. B. (2000) · Oncology · doi:10.1159/000012183 · Cited by 248
Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma
Yahagi, N., Shimano, H., Hasegawa, K., Ohashi, K., Matsuzaka, T., Najima, Y., Sekiya, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.037 · Cited by 248
Selective activation of the fatty acid synthesis pathway in human prostate cancer
Swinnen, J. V., Vanderhoydonc, F., Elgamal, A. A., Eelen, M., Vercaeren, I., Joniau, S., Van Poppel, H., Baert, L., Goossens, K., Heyns, W., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001015)88:2<176::aid-ijc5>3.0.co;2-3 · Cited by 245
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Bull, U., & Jakse, G. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66366-3 · Cited by 240
Targeting tumor cell metabolism with statins
Clendening, J. W., & Penn, L. Z. (2012) · Oncogene · doi:10.1038/onc.2012.6 · Cited by 239
Human fatty acid synthase: properties and molecular cloning.
Jayakumar, A., Tai, M. H., Huang, W. Y., al-Feel, W., Hsu, M., Abu-Elheiga, L., Chirala, S. S., & Wakil, S. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8695 · Cited by 231
Huang, W.-C., Li, X., Liu, J., Lin, J., & Chung, L. W. K. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0206 · Cited by 228
Dillard, P. R., Lin, M.-F., & Khan, S. A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.013 · Cited by 225
Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen, J. V., Esquenet, M., Goossens, K., Heyns, W., & Verhoeven, G. (1997) · PubMed · Cited by 225
Yoon, S., Lee, M.-Y., Park, S. W., Moon, J.-S., Koh, Y.-K., Ahn, Y.-H., Park, B.-W., & Kim, K.-S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702854200 · Cited by 224
Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis.
Kumar‐Sinha, C., Ignatoski, K. W., Lippman, M. E., Ethier, S. P., & Chinnaiyan, A. M. (2003) · PubMed · Cited by 222
DeBerardinis, R. J., Lum, J. J., & Thompson, C. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608372200 · Cited by 221
Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
Zhou, W., Simpson, P. J., McFadden, J. M., Townsend, C. A., Medghalchi, S. M., Vadlamudi, A., Pinn, M. L., Ronnett, G. V., & Kuhajda, F. P. (2003) · PubMed · Cited by 216
de Sande, T. V., Schrijver, E. D., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2002) · PubMed · Cited by 209
Shurbaji, M. S., Kalbfleisch, J. H., & Thurmond, T. S. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90218-x · Cited by 208
Liu, Y., Zuckier, L. S., & Ghesani, N. V. (2010) · PubMed · Cited by 208
The Primary Cilium in Cell Signaling and Cancer
Michaud, E. J., & Yoder, B. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0462 · Cited by 201
Tamura, K., Makino, A., Hullin-Matsuda, F., Kobayashi, T., Furihata, M., Chung, S., Ashida, S., Miki, T., Fujioka, T., Shuin, T., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0775 · Cited by 201
Wang, H. Q., Altomare, D. A., Skele, K. L., Poulikakos, P. I., Kuhajda, F. P., Di Cristofano, A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208463 · Cited by 198
Adiponectin as a growth inhibitor in prostate cancer cells
Bub, J. D., Miyazaki, T., & Iwamoto, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.103 · Cited by 198
Swinnen, J. V., Heemers, H., Deboel, L., Foufelle, F., Heyns, W., & Verhoeven, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203889 · Cited by 196
Bui, T., & Thompson, C. B. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.05.012 · Cited by 195
Yang, Y. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5600 · Cited by 193
Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat
Pemble, C. W., Johnson, L. C., Kridel, S. J., & Lowther, W. T. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1265 · Cited by 186
Inhibition of Fatty Acid Synthase Induces Endoplasmic Reticulum Stress in Tumor Cells
Little, J. L., Wheeler, F. B., Fels, D. R., Koumenis, C., & Kridel, S. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1794 · Cited by 181
Michalakis, K., Williams, C. J., Mitsiades, N., Blakeman, J., Balafouta-Tselenis, S., Giannopoulos, A., & Mantzoros, C. S. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0621 · Cited by 180
Chen, Y., & Hughes-Fulford, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010101)91:1<41::aid-ijc1009>3.0.co;2-2 · Cited by 179
Metabolic alterations and targeted therapies in prostate cancer
Flavin, R., Zadra, G., & Loda, M. (2011) · The Journal of Pathology · doi:10.1002/path.2809 · Cited by 178
Self-citationBowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/dc06-0997 · Cited by 175
Cell Cycle–Dependent Ciliogenesis and Cancer
Plotnikova, O. V., Golemis, E. A., & Pugacheva, E. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5838 · Cited by 171
Morrish, F. M., Noonan, J., Olsen, C. P., Gafken, P. R., Fitzgibbon, M., Kelleher, J. K., VanGilst, M., & Hockenbery, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141606 · Cited by 171
Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice
Alli, P. M., Pinn, M. L., Jaffee, E. M., McFadden, J. M., & Kuhajda, F. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208174 · Cited by 167
A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk
Chavarro, J. E., Stampfer, M. J., Li, H., Campos, H., Kurth, T., & Ma, J. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-1033 · Cited by 166
Peroxisomal branched chain fatty acid ?-oxidation pathway is upregulated in prostate cancer
Zha, S., Ferdinandusse, S., Hicks, J. L., Denis, S., Dunn, T. A., Wanders, R. J., Luo, J., De Marzo, A. M., & Isaacs, W. B. (2005) · The Prostate · doi:10.1002/pros.20177 · Cited by 164
Small Molecule Antagonizes Autoinhibition and Activates AMP-activated Protein Kinase in Cells
Pang, T., Zhang, Z., Gu, M., Qiu, B., Yu, L.-F., Cao, P.-R., Shao, W., Su, M., Li, J.-Y., Nan, F., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710114200 · Cited by 161
Caveolin-1 Promotes Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer
Williams, T. M., Hassan, G. S., Li, J., Cohen, A. W., Medina, F., Frank, P. G., Pestell, R. G., Di Vizio, D., Loda, M., & Lisanti, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501186200 · Cited by 160
Self-citationCrowe, F. L., Allen, N. E., Appleby, P. N., Overvad, K., Aardestrup, I. V., Johnsen, N. F., Tjønneland, A. M., Linseisen, J., Kaaks, R., Boeing, H., et al. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26369 · Cited by 160
Li, H., Stampfer, M. J., Mucci, L. A., Rifai, N., Qiu, W., Kurth, T., & Ma, J. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.133272 · Cited by 159
The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry
Morrish, F. M., Neretti, N., Sedivy, J. M., & Hockenbery, D. M. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5739 · Cited by 158
Vāvere, A. L., Kridel, S. J., Wheeler, F. B., & Lewis, J. S. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046672 · Cited by 154
Mostaghel, E. A., Solomon, K. R., Pelton, K., Freeman, M. R., & Montgomery, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030062 · Cited by 146
Shamma, A., Takegami, Y., Miki, T., Kitajima, S., Noda, M., Obara, T., Okamoto, T., & Takahashi, C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.001 · Cited by 140
Fiorentino, M., Zadra, G., Palescandolo, E., Fedele, G., Bailey, D., Fiore, C., Nguyen, P. L., Migita, T., Zamponi, R., Vizio, D. D., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.97 · Cited by 139
Self-citationKochuparambil, S. T., Al-Husein, B. A., Goc, A., Soliman, S. M., & Somanath, P. R. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.174870 · Cited by 137
de Sande, T. V., Roskams, T., Lerut, E., Joniau, S., Poppel, H. V., Verhoeven, G., & Swinnen, J. V. (2005) · The Journal of Pathology · doi:10.1002/path.1760 · Cited by 136
Suburu, J., & Chen, Y. Q. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.03.003 · Cited by 135
Zaidi, N., Royaux, I. E., Swinnen, J. V., & Smans, K. A. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0095 · Cited by 130
Nguyen, P., Ma, J., Chavarro, J., Freedman, M., Lis, R., Fedele, G., Fiore, C., Qiu, W., Fiorentino, M., Finn, S., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0793 · Cited by 129
Self-citationMoon, J.-S., Jin, W.-J., Kwak, J.-H., Kim, H.-J., Yun, M.-J., KIM, J.-W., Park, S. W., & Kim, K.-S. (2011) · Biochemical Journal · doi:10.1042/bj20101104 · Cited by 125
A Western-Type Diet Accelerates Tumor Progression in an Autochthonous Mouse Model of Prostate Cancer
Llaverı́as, G., Danilo, C., Wang, Y., Witkiewicz, A. K., Daumer, K. M., Lisanti, M. P., & Frank, P. G. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100568 · Cited by 124
Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors
Liu, G., Lynch, J. K., Freeman, J. C., Liu, B., Xin, Z., Zhao, H., Serby, M. D., Kym, P. R., Suhar, T. S., Smith, H. T., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070219p · Cited by 122
Lee, K., Hsu, E., Guh, J., Yang, M., Wang, D.-S., Kulp, S. K., Shapiro, C. L., & Chen, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264598 · Cited by 114
Neither LKB1 Nor AMPK Are the Direct Targets of Metformin
Hardie, D. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.07.032 · Cited by 113
Moreno-Andrés, D., Knecht, E., Viollet, B., & Sanz, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.06.044 · Cited by 98
Roy, M., Kung, H., & Ghosh, P. (2011) · Europe PMC (PubMed Central) · Cited by 93
Polyunsaturated fatty acid metabolism in prostate cancer
Berquin, I. M., Edwards, I. J., Kridel, S. J., & Chen, Y. Q. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9299-7 · Cited by 88
Choline Kinase Is a Novel Oncogene that Potentiates RhoA-Induced Carcinogenesis
de Molina, A. R., Gallego‐Ortega, D., Sarmentero, J., Báñez-Coronel, M., Martín-Cantalejo, Y., & Lacal, J. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4416 · Cited by 87
Beyond AICA riboside: In search of new specific AMP‐activated protein kinase activators
Guigas, B., Sakamoto, K., Taleux, N., Reyna, S. M., Musi, N., Viollet, B., & Hue, L. (2009) · IUBMB Life · doi:10.1002/iub.135 · Cited by 86
Grundmark, B., Garmo, H., Loda, M. F., Busch, C., Holmberg, L., & Zethelius, B. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0112 · Cited by 84
Self-citationPark, S., Wilkens, L. R., Henning, S. M., Marchand, L. L., Gao, K., Goodman, M. T., Murphy, S. P., Henderson, B. E., & Kolonel, L. N. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9236-4 · Cited by 82
Elevated α-Methylacyl-CoA Racemase Enzymatic Activity in Prostate Cancer
Kumar‐Sinha, C., Shah, R. B., Laxman, B., Tomlins, S. A., Harwood, J., Schmitz, W., Conzelmann, E., Sanda, M. G., Wei, J. T., Rubin, M. A., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63167-7 · Cited by 79
Problems with the Assessment of Dietary Fat in Prostate Cancer Studies
Dennis, L. K. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh243 · Cited by 78
Sartor, O. A. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-18 · Cited by 73
New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK
Zadra, G., Priolo, C., Patnaik, A., & Loda, M. F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1955 · Cited by 70
Self-citationConsumption of high ω-3 fatty acid diet suppressed prostate tumorigenesis in C3(1) Tag mice
Akinsete, J. A., Ion, G., Witte, T. R., & Hardman, W. E. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr238 · Cited by 67
Obesity and Prostate Cancer: A Growing Problem
Freedland, S. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1305 · Cited by 66
Tomek, K., Wagner, R., Varga, F., Singer, C. F., Karlic, H., & Grunt, T. W. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0467 · Cited by 64
Saturated fat intake predicts biochemical failure after prostatectomy
Strom, S. S., Yamamura, Y., Forman, M. R., Pettaway, C. A., Barrera, S. L., & DiGiovanni, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23414 · Cited by 62
Molecular imaging of prostate cancer
Fox, J. J., Schöder, H. M., & Larson, S. M. (2012) · Current Opinion in Urology · doi:10.1097/mou.0b013e32835483d5 · Cited by 62
Williams, T. M., Hassan, G. S., Li, J., Cohen, A. W., Medina, F., Frank, P. G., Pestell, R. G., Vizio, D. D., Loda, M. F., & Lisanti, M. P. (2005) · The Journal of Urology · doi:10.1016/s0022-5347(05)00110-2 · Cited by 56
Self-citationZinc and zinc ligands in human seminal plasma
Arver, S. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb10600.x · Cited by 54
Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer
Wang, S., Wu, J., Suburu, J., Gu, Z., Cai, J., Axanova, L. S., Cramer, S. D., Thomas, M. J., Perry, D. L., Edwards, I. J., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr290 · Cited by 53
Self-citationHorikoshi, M., Hara, K., Ohashi, J., Miyake, K., Tokunaga, K., Ito, C., Kasuga, M., Nagai, R., & Kadowaki, T. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0727 · Cited by 52
Current and emerging treatment modalities for metastatic castration‐resistant prostate cancer
Bracarda, S., Logothetis, C. J., Sternberg, C. N., & Oudard, S. M. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.10036.x · Cited by 51
Dietary fatty acid quality affects AR and PPARγ levels and prostate growth
Escobar, E. L. O., Gomes‐Marcondes, M. C. C., & Carvalho, H. F. (2009) · The Prostate · doi:10.1002/pros.20905 · Cited by 47
Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors
Koltun, D. O., Vasilevich, N. I., Parkhill, E. Q., Glushkov, A. I., Zilbershtein, T. M., Mayboroda, E. I., Boze, M. A., Cole, A. G., Henderson, I. M., Zautke, N. A., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.004 · Cited by 45
Willemarck, N., Rysman, E., Brusselmans, K., Imschoot, G. V., Vanderhoydonc, F., Moerloose, K., Lerut, E., Verhoeven, G., Roy, F. M. V., Vleminckx, K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2324 · Cited by 43
Advanced therapy of prostate disease
Resnick, E. B. M. I., & Thompson, I. M. (2000) · Cited by 39
Genomewide linkage analysis of familial prostate cancer in the Japanese population
Matsui, H., Suzuki, K., Ohtake, N., Nakata, S., Takeuchi, T., Yamanaka, H., & Inoue, I. (2003) · Journal of Human Genetics · doi:10.1007/s10038-003-0099-y · Cited by 39
Caveolin-1 and Prostate Cancer Progression
Freeman, M. R., Yang, W., & Vizio, D. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1222-9_7 · Cited by 37
Metabolic Syndrome and Prostate Cancer: A Review
Nobes, J. P., Langley, S. E. M., & Laing, R. W. (2008) · Clinical Oncology · doi:10.1016/j.clon.2008.11.013 · Cited by 35
PET Imaging of Prostate Cancer Using 11C-Acetate
Czernin, J. G., Benz, M., & Allen-Auerbach, M. (2009) · PET Clinics · doi:10.1016/j.cpet.2009.05.001 · Cited by 34
García-García, C., Fumarola, C., Navaratnam, N., Carling, D., & López‐Rivas, A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.022 · Cited by 31
Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors
Koltun, D. O., Zilbershtein, T. M., Migulin, V. A., Vasilevich, N. I., Parkhill, E. Q., Glushkov, A. I., McGregor, M. J., Brunn, S. A., Chu, N., Hao, J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.017 · Cited by 29
Liu, X., Fu, Y., & Meadows, G. G. (2011) · Oncology Letters · doi:10.3892/ol.2011.237 · Cited by 23
Emonds, K., Swinnen, J. V., van Weerden, W. M., Vanderhoydonc, F., Nuyts, J. L., Mortelmans, L., & Mottaghy, F. M. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1861-6 · Cited by 21
Mener, D. J. (2010) · IUBMB Life · doi:10.1002/iub.355 · Cited by 18
Lloyd, J. C., Antonelli, J. A., Phillips, T. E., Masko, E. M., Thomas, J.-A., Poulton, S. H. M., Pollak, M., & Freedland, S. J. (2010) · The Journal of Urology · doi:10.1016/j.juro.2009.12.003 · Cited by 15
Cited by
Milk nutritional composition and its role in human health
Pereira, P. C. (2014) · Nutrition · doi:10.1016/j.nut.2013.10.011 · Cited by 806
The role of the microbiome in cancer development and therapy
Bhatt, A. P., Redinbo, M. R., & Bultman, S. J. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21398 · Cited by 653
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Self-citationFatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Qu, Q., Zeng, F., Liu, X., Wang, Q. J., & Deng, F. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.132 · Cited by 545
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer
Watt, M. J., Clark, A. K., Selth, L. A., Haynes, V. R., Lister, N., Rebello, R., Porter, L. H., Niranjan, B., Whitby, S. T., Lo, J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5758 · Cited by 320
Metadata
- Authors
- Zadra, G., Photopoulos, C., & Loda, M.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Publisher
- Elsevier BV
- Published
- 2013-10
- Volume
- 1831
- Issue
- 10
- Pages
- 1518-1532
- ISSN
- 1388-1981 (ISSN-L)
- OpenAlex
- W2079474262
- Cited by
- 291
- References
- 199
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.